Inspire Medical appointed Michael H. Carrel to its Board as a Class III director, effective July 20, 2026, and named him to the Organization and Compensation Committee and the Quality, Product Supply and Technology Committee.
| IndividualMichael H. Carrel | RoleClass III Director; member, Organization and Compensation Committee; member, Quality, Product Supply and Technology Committee | Type of ChangeAppointed | Effective DateJuly 20, 2026 | ReasonAppointment by Board upon recommendation of Nominating and Corporate Governance Committee | Replacement InfoNot disclosed | Background DetailsPresident, CEO & director of AtriCure since Nov 2012; prior CEO roles at Vital Images and Zamba; CFO of NextNet Wireless; board experience includes Axonics (until 2024), MDMA, Advamed; B.S. Accounting (Penn State), MBA (Wharton) | Board/Committee Role ChangesAppointed to Organization and Compensation Committee and Quality, Product Supply and Technology Committee |
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.